MDCalc

Mekhail Extension of the Motzer Score

Predicts metastatic renal cell carcinoma survival, more accurately than the Motzer Score.

Normal: 140 U/L
Normal: <12 g/dL (120 g/L)

Diagnostic Result

Please fill out required fields.
Advice

The Motzer score (which performs similarly with or without the Mekhail extension) is among the most commonly used for mRCC, and is probably best used for selecting patients to enroll in clinical trials. The score retrospectively identified variables associated with survival, which may ultimately help predict outcomes.

Management

We are unaware of validated management algorithms using the score.

Critical Actions

The Motzer score (with or without the Mekhail extension) is not known to be accurate for individual survival prediction and should be considered a general guide rather than a concrete predictor.